INPRINT BIO LLC
MuscleInk: A multifunctional colloidal scaffold for the treatment of muscle loss
MuscleInk: A multifunctional colloidal scaffold for the treatment of muscle loss is a funding opportunity from INPRINT BIO LLC, up to 295481, closing November 30, 2026.
Nov 30, 2026
(122d left)Overview
PROJECT SUMMARY/ABSTRACT Volumetric muscle loss (VML), which refers to an en bloc deficit of skeletal muscle mass, commonly occurs following traumatic injury or tumor extirpation and results in substantial morbidity, pain, and disability. When VML occurs in the lower extremities, as is most common, it particularly…